Jana L Markley, Luting Fang, Andrew J Gasparrini, Chanez T Symister, Hirdesh Kumar, Niraj H Tolia, Gautam Dantas, Timothy A Wencewicz
ACS infectious diseases 2019 Apr 12The synthesis and biological evaluation of semisynthetic anhydrotetracycline analogues as small molecule inhibitors of tetracycline-inactivating enzymes are reported. Inhibitor potency was found to vary as a function of enzyme (major) and substrate-inhibitor pair (minor), and anhydrotetracycline analogue stability to enzymatic and nonenzymatic degradation in solution contributes to their ability to rescue tetracycline activity in whole cell Escherichia coli expressing tetracycline destructase enzymes. Taken collectively, these results provide the framework for the rational design of next-generation inhibitor libraries en route to a viable and proactive adjuvant approach to combat the enzymatic degradation of tetracycline antibiotics.
Jana L Markley, Luting Fang, Andrew J Gasparrini, Chanez T Symister, Hirdesh Kumar, Niraj H Tolia, Gautam Dantas, Timothy A Wencewicz. Semisynthetic Analogues of Anhydrotetracycline as Inhibitors of Tetracycline Destructase Enzymes. ACS infectious diseases. 2019 Apr 12;5(4):618-633
PMID: 30835428
View Full Text